Medbroker ApS: Financial statements 2023
CVR: 31892236
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Medbroker ApS (CVR 31892236) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -65,721 and a net result of DKK -404,955 compared with DKK -334,937 the year before. Equity in the 2023 report amounted to DKK 520,412. The solvency ratio was 79.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -65,721
- Profit/Loss
- DKK -404,955
- Equity
- DKK 520,412
- Total Assets
- DKK 656,262
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -66 t. | -405 t. | 520 t. | 1 |
| 2022 | - | -57 t. | -335 t. | 925 t. | 1 |
| 2021 | - | 130 t. | -343 t. | 1.3 mio. | 1 |
| 2020 | - | 646 t. | -182 t. | 1.6 mio. | 1 |
| 2019 | - | 1.1 mio. | 266 t. | 1.8 mio. | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Medbroker ApS has published its annual report for 2022. Gross profit came to DKK -56,504, and the net result was DKK -334,937.
About Medbroker ApS
Medbroker ApS is a Danish company of the type Anpartsselskab based in Gadstrup, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ORIGO BIOTECH ApS. The management consists of Henrik Carlheim Dørge. The board consists of Henrik Carlheim Dørge (chair). The company is owned by MEDBROKER INVEST ApS. The company has 3 employees (2023). In 2025, the company reported a gross profit of DKK -6,226 and a net result of DKK -78,938 compared with DKK -406,760 the year before. Equity in the 2025 report amounted to DKK 34,714.